The primary goal of NCI-MATCH is to determine whether targeted therapies can effectively treat cancers with specific genetic mutations. The trial also aims to expand the understanding of the relationship between genetic abnormalities and cancer behavior, thereby contributing to the broader field of precision oncology. Ultimately, NCI-MATCH seeks to identify new, effective treatments that could be integrated into standard cancer care.
